Abstract
Purpose To describe the short-term clinical outcomes for a cohort of patients undergoing first photocoagulation treatment for proliferative retinopathy or maculopathy in the United Kingdom.
Method Nine-month follow-up of the Royal College of Ophthalmologists' national audit of laser treatment for diabetic retinopathy. Results For eyes with maculopathy, 9.2% had had a deterioration in visual acuity equivalent to a doubling of the visual angle and 3.3% of eyes had a visual acuity of less than 6/60 at follow-up. There had been an improvement in the macular oedema or exudate in 64.6% and 77.3% respectively. Prognostic factors for a poorer visual acuity at follow-up were worse visual acuity at baseline, the presence of diffuse (vs focal) oedema and grid (vs focal) treatment. For eyes with proliferative retinopathy, the retinal neovascularisation had regressed fully in 50.8% of cases, whilst there had been no change or a deterioration in 10.3%. A visual acuity of less than 6/60 at follow-up was present in 8.6% of eyes. There was a poor morphological outcome at follow-up (as defined by rubeosis, new tractional detachment or having had a vitrectomy) in 7.2%. Risk factors for poor morphological outcome were the presence of ‘high-risk characteristics‘, female sex and the presence of concurrent maculopathy at baseline. Regression of neovascularisation was associated with greater areas of retinal ablation at the initial treatment session. Although some eyes with proliferative retinopathy appeared to be undertreated initially compared with DRS and ETDRS protocols, some of these eyes did respond to lower amounts of treatment.
Conclusion For maculopathy, poorer outcome was related to worse visual acuity at baseline, diffuse (vs focal) maculopathy, and grid treatment. For proliferative retinopathy, poorer outcome was related to ‘high-risk characteristics‘ and coexistence of maculopathy at baseline, and improvement was related to larger areas of ablation. The relationship of poor outcome with worse initial disease argues for earlier detection of retinopathy.
Similar content being viewed by others
Article PDF
References
British Multicentre Photocoagulation Trial. Proliferative diabetic retinopathy: treatment with xenon-arc photocoagulation. Interim report of a multicentre randomised controlled trial. BMJ 1977;1:739–41.
Hercules BL, Gayed II, Lucas SB, Jeacock J . Peripheral retinal ablation in the treatment of proliferative diabetic retinopathy: a three-year interim report of a randomised, controlled study using the argon laser. Br J Ophthalmol 1977;61:555–63.
Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study findings. DRS report no. 8. Ophthalmology 1981;88:583–600.
Blankenship GW . Diabetic macular edema and argon laser photocoagulation: a prospective randomized study. Ophthalmology 1979;86:69–78.
Patz A, Schatz H, Berkow JW . Macular edema: an overlooked complication of diabetic retinopathy. Trans Am Acad Ophthalmol Otolaryngol 1973;77:34–42.
Townsend C, Bailey J, Kohner E . Xenon arc photocoagulation for the treatment of diabetic maculopathy. Br J Ophthalmol 1980;64:385–91.
Olk RJ . Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 1986;93:938–50.
Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. ETDRS report no. 1. Arch Ophthalmol 1985;103:1796–806.
Evans J, Rooney C, Ashwood F, Dattani N, Wormald R . Blindness and partial sight in England and Wales: April 1990-March 1991. Health Trends 1996;28:5–12.
Diabetes care and research in Europe: the Saint Vincent Declaration. Diabet Med 1990;7:360.
Bailey CC, Sparrow JM, Grey RHB, Cheng H . The National Diabetic Retinopathy Laser Treatment Audit. I. Maculopathy. Eye 1998;12:69–76.
Desai P . The National Cataract Surgery Survey. II. Clinical outcomes. Eye 1993;7:489–94.
Grey RHB . The treatment of diabetic maculopathy by argon laser photocoagulation. Trans Ophthalmol Soc UK 1986;105:424–9.
Early Treatment Diabetic Retinopathy Study Research Group. Early Photocoagulation for diabetic retinopathy. ETDRS report no. 9. Ophthalomology 1991;98:766–85.
Doft B, Blankenship G . Retinopathy risk factor regression after laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 1984;91:1453–7.
Diabetic Retinopathy Study Research Group. Photocoagulation treatment of diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology 1978;85:82–106.
Bailey CC, Sparrow JM, Grey RHB, Cheng H . The National Diabetic Retinopathy Laser Treatment Audit. II. Proliferative retinopathy. Eye 1998;12:77–84.
Aylward GW, Pearson RV, Jagger JD, Hamilton AM . Extensive argon laser photocoagulation in the treatment of proliferative diabetic retinopathy. Br J Ophthalmol 1989;73:197–201.
Reddy VM, Zamora RL, Olk RJ . Quantitation of retinal ablation on proliferative diabetic retinopathy. Am J Ophthalmol 1995;119:760–6.
Diabetic Retinopathy Study Research Group. Macular edema in Diabetic Retinopathy Study patients. Ophthalmology 1987;94:754–60.
Author information
Authors and Affiliations
Additional information
This project was funded by the Department of Health
Rights and permissions
About this article
Cite this article
Bailey, C., Sparrow, J., Grey, R. et al. The national diabetic retinopathy laser treatment audit III. Clinical outcomes. Eye 13, 151–159 (1999). https://doi.org/10.1038/eye.1999.42
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/eye.1999.42
Keywords
This article is cited by
-
Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial
International Ophthalmology (2018)
-
Diagnose, Therapie und Verlaufskontrolle der diabetischen Augenerkrankung
Wiener klinische Wochenschrift (2012)
-
Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4
Eye (2011)
-
Why do patients still require surgery for the late complications of Proliferative Diabetic Retinopathy?
Eye (2010)
-
Typ-1-Diabetes mellitus: Spätkomplikationen im Kindes- und Jugendalter
Wiener Medizinische Wochenschrift (2010)